- Home
- MCBS vs XERS Comparison
MCBS vs XERS Comparison
Compare MCBS & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCBS
- XERS
- Stock Information
- Founded
- MCBS 2006
- XERS 2005
- Country
- MCBS United States
- XERS United States
- Employees
- MCBS N/A
- XERS N/A
- Industry
- MCBS Major Banks
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- MCBS Finance
- XERS Health Care
- Exchange
- MCBS Nasdaq
- XERS Nasdaq
- Market Cap
- MCBS 745.5M
- XERS 628.7M
- IPO Year
- MCBS 2019
- XERS 2018
- Fundamental
- Price
- MCBS $27.08
- XERS $4.51
- Analyst Decision
- MCBS Hold
- XERS Strong Buy
- Analyst Count
- MCBS 1
- XERS 6
- Target Price
- MCBS $34.00
- XERS $6.25
- AVG Volume (30 Days)
- MCBS 30.6K
- XERS 2.1M
- Earning Date
- MCBS 07-18-2025
- XERS 08-07-2025
- Dividend Yield
- MCBS 3.38%
- XERS N/A
- EPS Growth
- MCBS 30.91
- XERS N/A
- EPS
- MCBS 2.58
- XERS N/A
- Revenue
- MCBS $143,775,000.00
- XERS $222,551,000.00
- Revenue This Year
- MCBS $16.00
- XERS $35.03
- Revenue Next Year
- MCBS $31.75
- XERS $18.31
- P/E Ratio
- MCBS $10.42
- XERS N/A
- Revenue Growth
- MCBS 19.70
- XERS 29.88
- 52 Week Low
- MCBS $24.00
- XERS $2.03
- 52 Week High
- MCBS $36.15
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- MCBS 42.39
- XERS 46.97
- Support Level
- MCBS $27.14
- XERS $4.30
- Resistance Level
- MCBS $28.90
- XERS $4.79
- Average True Range (ATR)
- MCBS 0.57
- XERS 0.23
- MACD
- MCBS -0.12
- XERS -0.01
- Stochastic Oscillator
- MCBS 14.55
- XERS 25.93
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).